These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10410375)

  • 1. [Methods and criteria for studying polynuclear eosinophil activation].
    Couissinier-Paris P
    Med Trop (Mars); 1998; 58(4 Suppl):503-7. PubMed ID: 10410375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.
    Satoh T; Knowles A; Li MS; Sun L; Tooze JA; Zabucchi G; Spry CJ
    Immunology; 1994 Oct; 83(2):313-8. PubMed ID: 7835953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
    Simon HU; Plötz S; Simon D; Seitzer U; Braathen LR; Menz G; Straumann A; Dummer R; Levi-Schaffer F
    Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of surface molecules associated with physiologic activation of eosinophils. Application of whole-blood flow cytometry to eosinophils.
    Mawhorter SD; Stephany DA; Ottesen EA; Nutman TB
    J Immunol; 1996 Jun; 156(12):4851-8. PubMed ID: 8648134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
    Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
    Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of eosinophils in lysed whole blood using side scatter and CD16 negativity.
    Gopinath R; Nutman TB
    Cytometry; 1997 Dec; 30(6):313-6. PubMed ID: 9440823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eosinophils: receptors, mediators, functions].
    Prin L; Dubucquoi S
    Med Trop (Mars); 1998; 58(4 Suppl):433-6. PubMed ID: 10410361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human eosinophils express and release IL-13 following CD28-dependent activation.
    Woerly G; Lacy P; Younes AB; Roger N; Loiseau S; Moqbel R; Capron M
    J Leukoc Biol; 2002 Oct; 72(4):769-79. PubMed ID: 12377947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reactive hypereosinophilia in parasitic diseases].
    Ripert C
    Rev Prat; 2000 Mar; 50(6):602-7. PubMed ID: 10808314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunologic role of eosinophilic granulocytes within the scope of inflammatory lung diseases].
    Kroegel C
    Pneumologie; 1994 Feb; 48(2):74-84. PubMed ID: 8183873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients.
    Silveira-Lemos D; Teixeira-Carvalho A; Martins-Filho OA; Alves Oliveira LF; Costa-Silva MF; Matoso LF; de Souza LJ; Gazzinelli A; Corrêa-Oliveira R
    Acta Trop; 2008; 108(2-3):150-9. PubMed ID: 18550021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
    Lampinen M; Oberg G; Venge P; Carlson M
    APMIS; 2006 Nov; 114(11):757-63. PubMed ID: 17078855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune function of eosinophils: from antiparasite to antitumor cells.
    Legrand F; Woerly G; Driss V; Capron M
    Methods Mol Biol; 2008; 415():215-40. PubMed ID: 18370157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions.
    Bartemes KR; Cooper KM; Drain KL; Kita H
    J Allergy Clin Immunol; 2005 Oct; 116(4):827-35. PubMed ID: 16210057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The heart and the eosinophil].
    Touze JE; Fourcade L; Heno P; Mafart B; Mourot S
    Med Trop (Mars); 1998; 58(4 Suppl):459-64. PubMed ID: 10410366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophils induce DC maturation, regulating immunity.
    Lotfi R; Lotze MT
    J Leukoc Biol; 2008 Mar; 83(3):456-60. PubMed ID: 17991762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
    Sale R; Sabatini F; Silvestri M; Serpero L; Petecchia L; Rossi GA
    Int Immunopharmacol; 2004 Dec; 4(13):1687-96. PubMed ID: 15454120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in protein expression related to human eosinophil heterogeneity.
    Gruart V; Balloul JM; Prin L; Tomassini M; Loiseau S; Capron A; Capron M
    J Immunol; 1989 Jun; 142(12):4416-21. PubMed ID: 2723435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.